Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Incentive salience, not psychomotor sensitization or tolerance, drives escalation of cocaine self-administration in heterogeneous stock rats
    Published on 2026-01-16
    8 months ago
  • Oxytocin neurons in the anterior and posterior paraventricular nucleus have distinct behavioral functions and electrophysiological profiles
    Published on 2026-01-16
    8 months ago
  • Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophrenia
    Published on 2026-01-16
    8 months ago
  • Psychedelic therapeutics in psychiatric conditions
    Published on 2026-01-15
    8 months ago
  • Choreographing time: toward therapy-aligned entactogens for complex PTSD
    Published on 2026-01-15
    8 months ago
  • Psychotherapy for older adults with depression: a narrative review
    Published on 2026-01-14
    8 months ago
  • Consciousness, subjectivity, and aging in western thought
    Published on 2026-01-14
    8 months ago
« Previous 1 … 33 34 35 36 37 … 143 Next »
Journal of Psychopharmacology
  • What are set and setting: Reducing vagueness to improve research and clinical practice
    Published on 2025-05-26
    1 year ago
  • Centrally-acting opioid receptor antagonists as a treatment for antipsychotic-induced weight gain: A systematic review and meta-analysis of clinical trial data
    Published on 2025-05-23
    1 year ago
  • Psychedelic-assisted psychotherapy: The need to monitor adverse events
    Published on 2025-05-21
    1 year ago
  • Mapping acute alcohol effects on bodily sensations: A cross-dimensional interoceptive approach
    Published on 2025-05-20
    1 year ago
  • Comparative efficacy, tolerability, and acceptability of aducanumab, lecanemab, and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer’s disease: A systematic review and network meta-analysis
    Published on 2025-05-19
    1 year ago
  • Neurotransmitter modulation of human facial emotion recognition
    Published on 2025-05-17
    1 year ago
  • Corrigendum: Is psychedelic use associated with cancer? Interrogating a half-century-old claim using contemporary population-level data
    Published on 2025-05-16
    1 year ago
« Previous 1 … 33 34 35 36 37 … 154 Next »
European Neuropsychopharmacology
  • Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study
    Published on 2025-02-09
    2 years ago
  • Preliminary evidence should be treated as such: Response to “Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?”
    Published on 2025-02-05
    2 years ago
  • A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder
    Published on 2025-02-05
    2 years ago
  • Classical psychedelics in therapy: Essential psychotherapy or minimal support?
    Published on 2025-02-05
    2 years ago
  • Differential effects of Xanomeline-trospium chloride on positive and negative symptoms in Schizophrenia: The role of dose
    Published on 2025-02-05
    2 years ago
  • Lack of antidepressant-like effect of imipramine, fluoxetine and ketamine in the forced swim test in mice: How much standardization does a positive control require?
    Published on 2025-02-05
    2 years ago
  • Disease continuum centered on Parkinson’s disease
    Published on 2025-02-05
    2 years ago
« Previous 1 … 33 34 35 36 37 … 170 Next »

   Pharma Pub